AI-augmented Drug Discovery

Creative Biolabs provides a series of AI-augmented antibody discovery services to find rare antibody clusters, to expand antibody diversity, to create optimized antibody sequences, eventually to accelerate antibody drug discovery. AI can typically generate 10 times more antibody sequence clusters than a laboratory-based approach alone. Diversity leads to the discovery of new binding modalities and potentially new therapeutic modes-of-action.